标题
Atypical Antipsychotic-Induced Weight Gain
作者
关键词
-
出版物
CNS DRUGS
Volume 25, Issue 12, Pages 1035-1059
出版商
Springer Nature
发表日期
2011-11-09
DOI
10.2165/11596300-000000000-00000
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Iloperidone: A new drug for the treatment of schizophrenia
- (2011) S. A. Arif et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Metabolic Testing Rates in 3 State Medicaid Programs After FDA Warnings and ADA/APA Recommendations for Second-Generation Antipsychotic Drugs
- (2010) Elaine H. Morrato et al. ARCHIVES OF GENERAL PSYCHIATRY
- Errors in Table and Text in: Metabolic Screening in Children Receiving Antipsychotic Drug Treatment
- (2010) ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
- Olanzapine treatment and metabolic dysfunction: a dose response study in female Sprague Dawley rats
- (2010) Katrina Weston-Green et al. BEHAVIOURAL BRAIN RESEARCH
- Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?
- (2010) Richard Mailman et al. CURRENT PHARMACEUTICAL DESIGN
- Risperidone associated weight, leptin, and anthropometric changes in children and adolescents with psychotic disorders in early treatment
- (2010) Lawrence A. Maayan et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Abnormal correlation between serum leptin levels and body mass index may predict metabolic dysfunction irrespective of the psychopharmacological treatment
- (2010) David Marquina et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Prevalence and Trends in Obesity Among US Adults, 1999-2008
- (2010) Katherine M. Flegal JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Endocannabinoid Pro129Thr FAAH Functional Polymorphism But Not 1359G/A CNR1 Polymorphism Is Associated With Antipsychotic-Induced Weight Gain
- (2010) Palmiero Monteleone et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- What Is the Mechanism for Aripiprazole's Effect on Reducing Olanzapine-Associated Obesity?
- (2010) Chao Deng et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A Common Polymorphism in the Cannabinoid Receptor 1 (CNR1) Gene is Associated with Antipsychotic-Induced Weight Gain in Schizophrenia
- (2010) Arun K Tiwari et al. NEUROPSYCHOPHARMACOLOGY
- Profiling of Energy Metabolism in Olanzapine-Induced Weight Gain in Rats and Its Prevention by the CB1-Antagonist AVE1625
- (2010) Michaela Liebig et al. Obesity
- Potential mechanisms of atypical antipsychotic-induced metabolic derangement: Clues for understanding obesity and novel drug design
- (2010) Roberto Coccurello et al. PHARMACOLOGY & THERAPEUTICS
- The time-dependent change of insulin secretion in schizophrenic patients treated with olanzapine
- (2010) Chih-Chiang Chiu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone
- (2010) Seung-Yup Lee et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents
- (2010) Mark D. Black et al. PSYCHOPHARMACOLOGY
- Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
- (2010) Christine Rummel-Kluge et al. SCHIZOPHRENIA RESEARCH
- Prevalence of metabolic syndrome among patients with schizophrenia in Japan
- (2010) Norio Sugawara et al. SCHIZOPHRENIA RESEARCH
- Low prevalence of obesity and metabolic syndrome in never-treated chronic schizophrenia
- (2010) Ramachandran Padmavati et al. SCHIZOPHRENIA RESEARCH
- The metabolic syndrome and its constituting variables in atypical antipsychotic-treated subjects: Comparison with other drug treatments, drug-free psychiatric patients, first-degree relatives and the general population in Venezuela
- (2010) Trino Baptista et al. SCHIZOPHRENIA RESEARCH
- Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
- (2009) S. M. Stahl et al. ACTA PSYCHIATRICA SCANDINAVICA
- Obesity Among Those with Mental Disorders
- (2009) David B. Allison et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Short-term treatment with olanzapine does not modulate gut hormone secretion: olanzapine disintegrating versus standard tablets
- (2009) Solrun Vidarsdottir et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
- (2009) Christoph U. Correll JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Multiple Genetic Factors in Olanzapine-Induced Weight Gain in Schizophrenia Patients
- (2009) Hiroshi Ujike et al. JOURNAL OF CLINICAL PSYCHIATRY
- A 24-Week, Multicenter, Open-Label, Randomized Study to Compare Changes in Glucose Metabolism in Patients With Schizophrenia Receiving Treatment With Olanzapine, Quetiapine, or Risperidone
- (2009) John W. Newcomer et al. JOURNAL OF CLINICAL PSYCHIATRY
- Metabolic Risk Factors in Drug-Naive Patients With First-Episode Psychosis
- (2009) Swapna K. Verma et al. JOURNAL OF CLINICAL PSYCHIATRY
- Lurasidone in the Treatment of Acute Schizophrenia
- (2009) Mitsutaka Nakamura et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Comparison of the Effects of Olanzapine and Risperidone Versus Placebo on Ghrelin Plasma Levels
- (2009) James L. Roerig et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Effect of Antipsychotics on Peptides Involved in Energy Balance in Drug-Naive Psychotic Patients After 1 Year of Treatment
- (2009) Rocio Perez-Iglesias et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Predictors of Antipsychotic-Induced Weight Gain in First-Episode Psychosis
- (2009) Sahoo Saddichha et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Ghrelin and Leptin Levels in Schizophrenic Patients Treated With Antipsychotic Monotherapy
- (2009) Othman Sentissi et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Aripiprazole Added to Overweight and Obese Olanzapine-Treated Schizophrenia Patients
- (2009) David C. Henderson et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Polymorphisms of the LEP- and LEPR Gene and Obesity in Patients Using Antipsychotic Medication
- (2009) Jochem G. Gregoor et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Risperidone Treatment Increases CB1 Receptor Binding in Rat Brain
- (2009) Anna Secher et al. NEUROENDOCRINOLOGY
- Leptin Gene –2548G/A variants predict risperidone-associated weight gain in children and adolescents
- (2009) Chadi A. Calarge et al. PSYCHIATRIC GENETICS
- Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors
- (2009) Shona L. Kirk et al. PSYCHOPHARMACOLOGY
- Weight gain with clozapine: 8-year cohort naturalistic study among hospitalized Chinese schizophrenia patients
- (2009) Ya-Mei Bai et al. SCHIZOPHRENIA RESEARCH
- Biochemical risk factors for development of obesity in first-episode schizophrenia
- (2009) Robert Bodén et al. SCHIZOPHRENIA RESEARCH
- Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol
- (2009) Menahem Krakowski et al. SCHIZOPHRENIA RESEARCH
- An Exploration of the Effect of Modafinil on Olanzapine Associated Weight Gain in Normal Human Subjects
- (2008) James L. Roerig et al. BIOLOGICAL PSYCHIATRY
- Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT6 receptors: A comparative study of coupling to Gαs
- (2008) Delphine S. Dupuis et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The effects of antipsychotics on the density of cannabinoid receptors in the dorsal vagal complex of rats: implications for olanzapine-induced weight gain
- (2008) Katrina Weston-Green et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Do Internists, Pediatricians, and Psychiatrists Feel Competent in Obesity Care?
- (2008) Melanie Jay et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Body Weight and Plasma Levels of Ghrelin and Leptin during Treatment with Olanzapine
- (2008) Bong-Jo Kim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Antipsychotic-induced body weight gain: Predictors and a systematic categorization of the long-term weight course
- (2008) Stefan Gebhardt et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Ziprasidone and aripiprazole attenuate olanzapine-induced hyperphagia in rats
- (2008) S. Snigdha et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
- (2008) René S Kahn et al. LANCET
- The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines
- (2008) Robin L. Thurmond et al. NATURE REVIEWS DRUG DISCOVERY
- The Orexigenic Effect of Ghrelin Is Mediated through Central Activation of the Endogenous Cannabinoid System
- (2008) Blerina Kola et al. PLoS One
- Effects of second generation antipsychotics on leptin and ghrelin
- (2008) Ayşen Esen-Danacı et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Decreased levels of ghrelin, cortisol, and fasting blood sugar, but not n-octanoylated ghrelin, in Japanese schizophrenic inpatients treated with olanzapine
- (2008) Kazuhide Tanaka et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression
- (2008) Mei Han et al. PSYCHONEUROENDOCRINOLOGY
- Differential Effects of Various Typical and Atypical Antipsychotics on Plasma Glucose and Insulin Levels in the Mouse: Evidence for the Involvement of Sympathetic Regulation
- (2008) Y. E. Savoy et al. SCHIZOPHRENIA BULLETIN
- Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin
- (2008) Hua Jin et al. SCHIZOPHRENIA RESEARCH
- Frequency of abnormal correlation between leptin and the body mass index during first and second generation antipsychotic drug treatment
- (2008) R PENA et al. SCHIZOPHRENIA RESEARCH
- World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia
- (2008) Rajiv Tandon et al. SCHIZOPHRENIA RESEARCH
- Are metabolic indices different between drug-naïve first-episode psychosis patients and healthy controls?
- (2008) S SENGUPTA et al. SCHIZOPHRENIA RESEARCH
- Anti-obesity drugs and neural circuits of feeding
- (2008) R ADAN et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Effects of chronic treatment of olanzapine and haloperidol on peptide YY binding densities in the rat brain
- (2007) Qing Wang et al. EXPERIMENTAL NEUROLOGY
- Selective 5-HT6 receptor ligands: Progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders
- (2007) D.J. Heal et al. PHARMACOLOGY & THERAPEUTICS
- Leptin and Ghrelin Levels in Patients With Schizophrenia During Different Antipsychotics Treatment: A Review
- (2007) O. Sentissi et al. SCHIZOPHRENIA BULLETIN
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started